# OnCo record paper-tung-tbcrc048-expansion-jco-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-tung-tbcrc048-expansion-jco-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-tung-tbcrc048-expansion-jco-2026" ;
  schema:name "TBCRC 048 expansion: olaparib in metastatic breast cancer with germline PALB2 or somatic BRCA"@en ;
  schema:description "Olaparib shrank some metastatic breast cancers with tumour-only BRCA mutations. This does not establish benefit in preventing recurrence after surgery."@en ;
  schema:url <https://onco.cc/key-papers/paper-tung-tbcrc048-expansion-jco-2026/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO-25-02075>, <https://pubmed.ncbi.nlm.nih.gov/41604601/> ;
  schema:sameAs <https://doi.org/10.1200/JCO-25-02075> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Tung NM, Robson ME, Li T, et al." ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:trials <https://onco.cc/trials/nct03344965/> .